COR

Cencora, Inc.
$340.43
-2.84 (-0.83%)
Mkt Cap 64.96B
Volume 1,514,582
52W Range 244.82-377.54
Sector Healthcare
Beta 0.58
EPS (TTM) 13.52 USD
P/E Ratio 25.18
Revenue (TTM) 332.77B USD
Rev Growth (5Y) +11.1%
EPS Growth (5Y) +2.0%
AlphaVal · Fair Value
What we estimate one share is worth
$137.87
Overvalued strong signal
146.9% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B+
Stable Earnings Power
77.6 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 321.33B 293.96B 262.17B 238.59B 213.99B 189.89B 179.59B 167.94B 153.14B 146.85B 135.96B 119.57B
Net Income 1.55B 1.51B 1.75B 1.70B 1.54B (3.40B) 855.37M 1.66B 414.48M 1.43B (134.89M) 276.48M
EPS 8.02 7.60 8.62 8.15 7.48 -16.60 4.07 7.61 1.67 6.73 -0.62 1.22
Free Cash Flow 3.21B 3.00B 3.45B 2.21B 2.23B 1.84B 2.03B 1.07B 1.02B 2.71B 3.69B 1.20B
FCF / Share 16.55 15.10 16.88 10.59 10.82 8.97 9.68 4.93 4.68 12.79 16.94 5.27
Operating CF 3.88B 3.48B 3.91B 2.70B 2.67B 2.21B 2.34B 1.41B 1.49B 3.18B 3.92B 1.46B
Total Assets 76.59B 67.10B 62.56B 56.56B 57.34B 44.27B 39.17B 37.67B 35.32B 33.59B 27.74B 21.53B
Total Debt 10.75B 6.65B 6.82B 7.59B 8.75B 4.98B 4.49B 4.66B 3.79B 4.46B 3.74B 2.00B
Cash & Equiv 4.39B 3.23B 2.69B 3.53B 2.55B 4.60B 3.37B 2.49B 2.44B 2.74B 2.17B 1.81B
Book Value 1.51B 645.94M 522.00M (211.56M) 223.35M (1.02B) 2.88B 2.93B 2.06B 2.13B 616.39M 1.96B
Return on Equity 1.03 2.34 3.34 N/A 6.89 N/A 0.30 0.57 0.20 0.67 -0.22 0.14
COR News
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Passage Bio, Inc. (Nasdaq – PASG), American Oncology Network, Inc. (OTCQX – AONC), Utz Brands, Inc. (NYSE – UTZ), Finward Bancorp (Nasdaq – FNWD)
Oct 21, 2026 07:28 AM · globenewswire.com
Cencora to acquire American Oncology Network in $2.4 billion deal
Oct 21, 2026 03:38 AM · reuters.com
Cencora to Acquire American Oncology Network to Strengthen Support of Community Oncology
Oct 21, 2026 03:30 AM · businesswire.com
IFP Advisors Inc Purchases 14,078 Shares of Cencora, Inc. $COR
Oct 19, 2026 12:50 AM · defenseworld.net
Cencora, Inc. $COR Stake Increased by Frank Rimerman Advisors LLC
Oct 19, 2026 12:17 AM · defenseworld.net
Cencora (NYSE:COR) and Option Care Health (NASDAQ:OPCH) Financial Contrast
Oct 17, 2026 12:01 AM · defenseworld.net
AI Disruption May Benefit Cencora More Than Hims & Hers
Oct 14, 2026 05:38 AM · seekingalpha.com
23,420 Cencora, Inc. $COR Shares Bought by NorthCrest Asset Manangement LLC
Oct 13, 2026 03:55 AM · defenseworld.net
Hims & Hers Health (NYSE:HIMS) vs. Cencora (NYSE:COR) Head to Head Review
Oct 11, 2026 09:28 PM · defenseworld.net
Cencora Remains A Buy At These Prices, As Healthcare Supply-Chain Needs Grow
Oct 05, 2026 11:48 PM · seekingalpha.com